US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

26.91

+0.11000.41%

Volume:12.83K

Turnover:339.31K

Market Cap:60.41M

PE:- -

High:27.02

Open:26.43

Low:26.29

Close:26.80

52wk High:27.02

52wk Low:15.63

Shares:2.24M

Float Shares:2.24M

Volume Ratio:0.43

T/O Rate:0.57%

Dividend:1.70

Dividend Rate:6.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Compass Pathways initiated with an Equal Weight at Wells Fargo

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

Bristol-Myers Squibb Advances New Lung Cancer Combo Into Phase 2: What Investors Should Watch

Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy

Organon to present results from analysis of Phase 3 trials of VTAMA cream

Radiopharm outlines capital raising plans and risk warnings for oncology radiopharma platform

Lightning Minerals shareholders back all capital raising resolutions

Kringle Pharma Launches Additional Phase 3 Trial of Oremepermin Alfa in Acute Spinal Cord Injury

X2M Connect Plans Major Share and Option Issue on ASX

Dalaroo board backs A$1.75m raising to drive gold and rare earths push

Verastem doses first patient in TARGET-D 202 Phase 2 trial

Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results

NRX Pharmaceuticals - on July 21, Nrxd Selected by Darpa for Negotiation of Potential Sparc-tms Clinical Trial Award - SEC Filing

THOMSON REUTERS

Right Resources secures ASX waiver to advance shareholder-backed capital raising

Codeifai Plans Major ASX Placement of Shares and Options

Aguia Resources Raises $3 Million to Advance Phosphate and Gold Projects

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS

Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market

Alkermes Plc : Stifel Raises Target Price to $63 from $45

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PSIL/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":26.91,"timestamp":1787764125822,"preClose":26.8,"halted":0,"volume":12829,"delay":0,"changeRate":0.004104477611940278,"floatShares":2244976,"shares":2244976,"eps":0,"marketStatus":"Trading","change":0.11,"latestTime":"08-26 13:09:05 EDT","open":26.429,"high":27.0175,"low":26.29,"amount":339305.356161,"amplitude":0.027146,"askPrice":27.07,"askSize":1000,"bidPrice":26.56,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":26.8,"sharesOutstanding":1184976,"nav":25.732,"aum":57766911.89,"dividendRate":0.063356,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":26.9,"preClose":26.8,"latestTime":"08:45 EDT","volume":844,"amount":22607.829632,"timestamp":1787748339359,"change":0.1,"changeRate":0.003731,"amplitude":0.033955},"postHourTrading":{"tag":"盘后","latestPrice":26.88,"preClose":26.8,"latestTime":"19:32 EDT","volume":216,"amount":5804.83,"timestamp":1787700759051,"change":0.08,"changeRate":0.002985,"amplitude":0.002985},"volumeRatio":0.430652,"impliedVol":0.4009,"impliedVolPercentile":0.7251},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2244976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.430652,"shares":2244976,"dividePrice":1.7049,"high":27.0175,"amplitude":0.027146,"preClose":26.8,"low":26.29,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":26.91,"committee":-0.818182,"eps":0,"divideRate":0.063356,"volume":12829,"delay":0,"ttmEps":0,"open":26.429,"prevYearClose":17.17,"prevWeekClose":25.86,"prevMonthClose":23.5,"prevQuarterClose":24.05,"fiveDayClose":26.24,"twentyDayClose":23.23,"sixtyDayClose":21.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654016997","title":"Compass Pathways initiated with an Equal Weight at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016997?lang=en_us&edition=fundamental","pubTime":"2026-07-27 17:25","pubTimestamp":1785144306,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Benjamin Burnett initiated coverage of Compass Pathways (CMPS) with an Equal Weight rating and $13 price target While the two p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-pathways-initiated-with-an-equal-weight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-pathways-initiated-with-an-equal-weight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0175139822.USD","LU0130102774.USD","LU0971096721.USD","LU0640476718.USD","LU1267930227.SGD","LU0048573561.USD","LU1267930573.SGD","BK4139","LU1201861249.SGD","LU1894683264.USD","LU0314106906.USD","TFNS","LU2361045086.USD","BK4207","LU1791807156.HKD","IYF","LU0417517546.SGD","LU1074936037.SGD","LU0683600562.USD","LU1668664300.SGD","PGF","LU2461242641.AUD","BK4501","LU0320765489.SGD","LU0310799852.SGD","LU0211328371.USD","LU1894683348.USD","LU0251142724.SGD","LU0256863811.USD","LU1035773651.USD","CMPS","KBWB","IE000M9KFDE8.USD","LU0942090050.USD","LU0072461881.USD","LU0742534661.SGD","FTXO","BK4559","LU1267930490.SGD","PSIL","BK4585","BK4582","LU0029864427.USD","LU1363072403.SGD","LU2236285917.USD","LU0310800379.SGD","LU1069347547.HKD","IE0002270589.USD","LU2361044865.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654054554","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654054554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654054554?lang=en_us&edition=fundamental","pubTime":"2026-07-25 22:50","pubTimestamp":1784991019,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Celldex (CLDX) with bullish sent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","PSIL","XLV","PSCH","BK4139","IBRN","ALKS","BK4581","CLDX","HCSG","XBI","BK4585","LU0128526141.USD","MEDX","LU0029874061.USD","BK4137","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036222","title":"Bristol-Myers Squibb Advances New Lung Cancer Combo Into Phase 2: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036222?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:34","pubTimestamp":1784910898,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb is running a Phase 2 trial to test a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-advances-new-lung-cancer-combo-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-advances-new-lung-cancer-combo-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","LU1093756168.USD","LU0882574055.USD","LU1868836914.USD","BK4588","LU0061475181.USD","BBC","BK4211","LU1585245621.USD","LU0237698245.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU2242646821.SGD","LU0306807586.USD","LU1983299246.USD","LU0114720955.EUR","BMY","LU1670710588.SGD","LU1868837136.USD","LU1323610961.USD","LU1093756325.SGD","LU0306806265.USD","LU0985481810.HKD","LU2125154778.USD","PSIL","IE00B2B36J28.USD","BK4534","LU1261432733.SGD","LU1868836757.USD","LU0321505868.SGD","ISBC","BK4585","FTXH","LU1670711040.USD","LU0321505439.SGD","LU0225284248.USD","LU1868836591.USD","IHE","LU1074936037.SGD","BK4007","LU0267386448.USD","BK4532","BK4581","LU2125154935.USD","LU0225771236.USD","IE00BFXG1179.USD","IE00BFTCPJ56.SGD","LU1670710661.SGD","LU0432979614.USD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654362520","title":"Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK","url":"https://stock-news.laohu8.com/highlight/detail?id=2654362520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654362520?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:34","pubTimestamp":1784910878,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a Phase 3 trial to test elritercept (TA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-elritercept-trial-targets-anemia-in-myelofibrosis-raising-long-term-upside-for-tak?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-elritercept-trial-targets-anemia-in-myelofibrosis-raising-long-term-upside-for-tak?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","TAK","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036255","title":"Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036255","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036255?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:33","pubTimestamp":1784910829,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical study. Jazz Pharmaceuticals is preparing a Phase 3 trial to test a new o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jazz-pharmaceuticals-advances-phase-3-cannabidiol-trial-in-severe-childhood-epilepsy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jazz-pharmaceuticals-advances-phase-3-cannabidiol-trial-in-severe-childhood-epilepsy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204084","title":"Organon to present results from analysis of Phase 3 trials of VTAMA cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204084?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:11","pubTimestamp":1784895078,"startTime":"0","endTime":"0","summary":"Organon (OGN) will present results from a post hoc analysis of pooled data from the Phase 3 pivotal trials, ADORING 1 and ADORING 2, evaluating the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","BBC","FXH","BK4588","LU2065171311.SGD","LU2065169927.USD","LU2065170008.USD","OGN","BK4007","BK4559","PSIL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653702156","title":"Radiopharm outlines capital raising plans and risk warnings for oncology radiopharma platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2653702156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653702156?lang=en_us&edition=fundamental","pubTime":"2026-07-24 15:38","pubTimestamp":1784878698,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Radiopharm Theranostics Limited ( ($AU:RAD) ). Radiopharm Theranostics has released a capital raising presentat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-outlines-capital-raising-plans-and-risk-warnings-for-oncology-radiopharma-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-outlines-capital-raising-plans-and-risk-warnings-for-oncology-radiopharma-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653063997","title":"Lightning Minerals shareholders back all capital raising resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2653063997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653063997?lang=en_us&edition=fundamental","pubTime":"2026-07-24 13:03","pubTimestamp":1784869393,"startTime":"0","endTime":"0","summary":"An announcement from Lightning Minerals Ltd. ( ($AU:L1M) ) is now available. Lightning Minerals Ltd shareholders approved all resolutions put forwa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lightning-minerals-shareholders-back-all-capital-raising-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lightning-minerals-shareholders-back-all-capital-raising-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","MTX","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653708145","title":"Kringle Pharma Launches Additional Phase 3 Trial of Oremepermin Alfa in Acute Spinal Cord Injury","url":"https://stock-news.laohu8.com/highlight/detail?id=2653708145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653708145?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:52","pubTimestamp":1784861536,"startTime":"0","endTime":"0","summary":"Kringle Pharma, Inc. ( ($JP:4884) ) has shared an announcement. Kringle Pharma has launched an additional Phase 3 trial in Japan to evaluate oremep...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kringle-pharma-launches-additional-phase-3-trial-of-oremepermin-alfa-in-acute-spinal-cord-injury?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kringle-pharma-launches-additional-phase-3-trial-of-oremepermin-alfa-in-acute-spinal-cord-injury?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL","JP","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653772545","title":"X2M Connect Plans Major Share and Option Issue on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2653772545","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653772545?lang=en_us&edition=fundamental","pubTime":"2026-07-24 08:08","pubTimestamp":1784851687,"startTime":"0","endTime":"0","summary":"The latest update is out from X2M Connect Limited ( ($AU:X2M) ). X2M Connect Limited has notified the ASX of a proposed capital raising involving t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/x2m-connect-plans-major-share-and-option-issue-on-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/x2m-connect-plans-major-share-and-option-issue-on-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653399774","title":"Dalaroo board backs A$1.75m raising to drive gold and rare earths push","url":"https://stock-news.laohu8.com/highlight/detail?id=2653399774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653399774?lang=en_us&edition=fundamental","pubTime":"2026-07-24 06:44","pubTimestamp":1784846651,"startTime":"0","endTime":"0","summary":"Dalaroo Metals Ltd. ( ($AU:DAL) ) has shared an announcement. Dalaroo Metals has completed the second tranche of a capital raising, securing about ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dalaroo-board-backs-a1-75m-raising-to-drive-gold-and-rare-earths-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dalaroo-board-backs-a1-75m-raising-to-drive-gold-and-rare-earths-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["1OZmain","GDX","PSIL","PHYS","IAUM","GOLY","GDXU","GLL","JNUG","BTGD","UYM","SGDM","GLTR","FXZ","AAAU","GDXY","MVPS","REMX","PICK","DZZ","UGL","DAL","IAUI","USG","DGZ","DBC","DUST","XME","YGLD","CEF","DGP","JETS","FGDL","SGOL","GDXJ","GDXD","JDST","GLD","RING","BEGS","GLDM","BAR","CRIT","GOAU","OUNZ","DULL","GBUG","SHNY","IAU","PPI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653939797","title":"Verastem doses first patient in TARGET-D 202 Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653939797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653939797?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:06","pubTimestamp":1784750793,"startTime":"0","endTime":"0","summary":"Verastem (VSTM) Oncology announced that the first patient has been dosed in the TARGET-D 202 Phase 2 registration-directed trial evaluating VS-7375...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verastem-doses-first-patient-in-target-d-202-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verastem-doses-first-patient-in-target-d-202-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VSTM","BK4139","BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653623367","title":"Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653623367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653623367?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:01","pubTimestamp":1784739666,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals stock saw major gains after the company announced new results from a Phase 3 trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/arrowhead-pharmaceuticals-arwr-stock-soars-on-strong-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/arrowhead-pharmaceuticals-arwr-stock-soars-on-strong-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4585","BBC","BK4139","ARWR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653754039","title":"NRX Pharmaceuticals - on July 21, Nrxd Selected by Darpa for Negotiation of Potential Sparc-tms Clinical Trial Award - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653754039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653754039?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:08","pubTimestamp":1784718511,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0MI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NRXP","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653644758","title":"Right Resources secures ASX waiver to advance shareholder-backed capital raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2653644758","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653644758?lang=en_us&edition=fundamental","pubTime":"2026-07-22 16:12","pubTimestamp":1784707936,"startTime":"0","endTime":"0","summary":"Right Resources Limited ( ($AU:RRE) ) has provided an update. Right Resources Limited has outlined details of its proposed capital raising, combini...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/right-resources-secures-asx-waiver-to-advance-shareholder-backed-capital-raising?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/right-resources-secures-asx-waiver-to-advance-shareholder-backed-capital-raising?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653778286","title":"Codeifai Plans Major ASX Placement of Shares and Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2653778286","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653778286?lang=en_us&edition=fundamental","pubTime":"2026-07-22 08:37","pubTimestamp":1784680633,"startTime":"0","endTime":"0","summary":"YPB Group Ltd. ( ($AU:CDE) ) has shared an update. Codeifai Limited has announced a proposed capital raising involving the issue of new securities ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/codeifai-plans-major-asx-placement-of-shares-and-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/codeifai-plans-major-asx-placement-of-shares-and-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653781076","title":"Aguia Resources Raises $3 Million to Advance Phosphate and Gold Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2653781076","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653781076?lang=en_us&edition=fundamental","pubTime":"2026-07-22 08:13","pubTimestamp":1784679189,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aguia Resources Limited ( ($AU:AGR) ). Aguia Resources Limited has completed a $3 million capital raising via a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aguia-resources-raises-3-million-to-advance-phosphate-and-gold-projects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aguia-resources-raises-3-million-to-advance-phosphate-and-gold-projects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277231","title":"Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277231?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:34","pubTimestamp":1784637260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","MEDX","IBRN","PSCH","FBT","BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653171362","title":"Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2653171362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653171362?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:31","pubTimestamp":1784565094,"startTime":"0","endTime":"0","summary":"Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab has launched a Phase 3 trial testing petosemtamab plus chemotherap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmabs-petosemtamab-trial-takes-aim-at-a-key-colorectal-cancer-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmabs-petosemtamab-trial-takes-aim-at-a-key-colorectal-cancer-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652290391","title":"Alkermes Plc : Stifel Raises Target Price to $63 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2652290391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652290391?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:09","pubTimestamp":1784545792,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","MEDX","IBRN","BK4139","PSIL","PSCH","FBT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}